Indonesia, which has had more human cases of avian flu than any other country, has stopped sending samples of the virus to the World Health Organization (WHO), apparently because it is negotiating a contract to sell the samples to a US vaccine company, a WHO official said on Tuesday.
The strains of the H5N1 virus circulating in Indonesia are considered crucial to developing up-to-date vaccines and following mutations in the virus. The official, David Heymann, said the agency was "clearly concerned" about the development and was in talks with Indonesia.
Heymann, the agency's chief of communicable diseases, said he was not blaming the company involved, Baxter Healthcare of Deerfield, Illinois.
"But now that this has happened," he said, "we have to sit down and figure out how to rectify it."
Indonesia signed a memorandum of understanding with Baxter yesterday. Under the memorandum, which has yet to be finalized, Indonesia would provide samples of the H5N1 strain of bird flu and Baxter would develop a vaccine and help Indonesia set up its own production facilities.
Health Minister Siti Fadillah Supari said the agreement would secure an affordable supply of vaccine in the event of a national emergency in Indonesia.
"It is for our own use. If in the near future we need it, we would be ready," she said.
When approved for licensing, Indonesia would also have the right to market it domestically and export it to other countries, she said.
A Baxter spokeswoman said the company had not asked Indonesia to stop cooperating with the WHO. She added that the agreement would not give it exclusive access to Indonesian strains.
The virus has not yet mutated into a strain easily transmitted among humans. But it has infected 81 people in Indonesia, 63 of them fatally. It killed more people last year than in any previous year and is out of control in poultry in Indonesia, Egypt and West Africa.
Indonesia's decision upsets the pattern for making seasonal flu vaccines -- by choosing among hundreds of samples sent in voluntarily from all over the world -- and could set a dangerous example for other countries.
Indonesia and other poor countries feel slighted by the system -- justifiably so, some experts say -- because the samples they send in are used to produce vaccines that they often cannot afford.
"Their concern," Heymann said, "is that their strains have been used by several manufacturers to produce vaccines, and that Indonesia should get some compensation. From their point of view, it's understandable."
The country has not released a flu sample since late last year.
Getting affordable flu vaccines has not been a high priority for poor countries because they are worried about greater threats that can be prevented by vaccines -- including measles, polio, rotavirus and other killers of children -- and about medicine for AIDS.
But with the threat of a lethal flu looming and with Western companies able to produce enough vaccine each year for less than a quarter of the world, Indonesia is trying to secure an affordable supply for its people.
The Baxter spokeswoman, Deborah Spak, said the company had done nothing to encourage Indonesia to cut off WHO.
"Baxter has nothing to do with this," she said. "Our role is in developing vaccines. We're not involved in ownership decisions. We believe that the timely sharing of information is critical for improving international responses to the threat of a pandemic and are proud to be part of the global effort."
Some leading flu experts said they believed that Indonesia was acting on its own, not understanding the ramifications.
"This is counterproductive -- it will hurt Indonesia more than it hurts other countries," said Arnold Monto, an epidemiologist at the University of Michigan. "The WHO should be their biggest friend. Indonesia has a virus with a 70 percent case fatality, and we don't know why. If they want to work with the best laboratories in the world, they should make sure that virus samples can get out."
also see story:
The virus that could
The pitch is a classic: A young celebrity with no climbing experience spends a year in hard training and scales Mount Everest, succeeding against some — if not all — odds. French YouTuber Ines Benazzouz, known as Inoxtag, brought the story to life with a two-hour-plus documentary about his year preparing for the ultimate challenge. The film, titled Kaizen, proved a smash hit on its release last weekend. Young fans queued around the block to get into a preview screening in Paris, with Inoxtag’s management on Monday saying the film had smashed the box office record for a special cinema
CRITICISM: ‘One has to choose the lesser of two evils,’ Pope Francis said, as he criticized Trump’s anti-immigrant policies and Harris’ pro-choice position Pope Francis on Friday accused both former US president Donald Trump and US Vice President Kamala Harris of being “against life” as he returned to Rome from a 12-day tour of the Asia-Pacific region. The 87-year-old pontiff’s comments on the US presidential hopefuls came as he defied health concerns to connect with believers from the jungle of Papua New Guinea to the skyscrapers of Singapore. It was Francis’ longest trip in duration and distance since becoming head of the world’s nearly 1.4 billion Roman Catholics more than 11 years ago. Despite the marathon visit, he held a long and spirited
‘DISAPPEARED COMPLETELY’: The melting of thousands of glaciers is a major threat to people in the landlocked region that already suffers from a water shortage Near a wooden hut high up in the Kyrgyz mountains, scientist Gulbara Omorova walked to a pile of gray rocks, reminiscing how the same spot was a glacier just a few years ago. At an altitude of 4,000m, the 35-year-old researcher is surrounded by the giant peaks of the towering Tian Shan range that also stretches into China, Kazakhstan and Uzbekistan. The area is home to thousands of glaciers that are melting at an alarming rate in Central Asia, already hard-hit by climate change. A glaciologist, Omarova is recording that process — worried about the future. She hiked six hours to get to
The number of people in Japan aged 100 or older has hit a record high of more than 95,000, almost 90 percent of whom are women, government data showed yesterday. The figures further highlight the slow-burning demographic crisis gripping the world’s fourth-biggest economy as its population ages and shrinks. As of Sept. 1, Japan had 95,119 centenarians, up 2,980 year-on-year, with 83,958 of them women and 11,161 men, the Japanese Ministry of Health said in a statement. On Sunday, separate government data showed that the number of over-65s has hit a record high of 36.25 million, accounting for 29.3 percent of